Hjem › Alvorlig depressiv lidelse › Arkansas
Alvorlig depressiv lidelse kliniske forsøg i Arkansas
15 studier for Alvorlig depressiv lidelse søger deltagere på steder i Arkansas.
Byer i Arkansas
Officiel studietekst (engelsk)
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 25. sep. 2026 · NCT06559306Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Little Rock
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 24. sep. 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Bryant
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pillar Clinical Research, Bentonville
- SanRo Clinical Research Group, Bryant
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 8. sep. 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07610473A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Bentonville
- Draig Clinical Site, Little Rock
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 26. aug. 2026 · NCT07300969NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06911112A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Preferred Research Partners, Inc., Little Rock
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 10. aug. 2026 · NCT07592689A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
- Woodland International Research Group, Little Rock
- Woodland Research Northwest, Rogers
RekruttererFase 3
Alder 18 til 74 · Alle køn · Opdateret 3. aug. 2026 · NCT06775379Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Bryant
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT06966401A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 15. jun. 2026 · NCT07276997A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
- Woodland Research Northwest, Rogers
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 11. maj 2026 · NCT06524830Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Little Rock
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. okt. 2025 · NCT06786624Study of ALTO-300 in MDD
- Site 193, Rogers
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.